Accumulation of a fatty compound called ceramide in the lungs could set the stage for the chronic lung infections of cystic fibrosis, a study in mice suggests. The finding offers a new twist on the still-unresolved course of this hereditary disease.
Patients with cystic fibrosis have a mutation in the CFTR gene.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.